Friday, November 2, 2012

DNA biomarker test Multiple Myeloma

The malignant blood cell cancer can provide many can provide many challenges for physicians trying to treat individuals with Multiply Myeloma. 
But Empire Genomics says this new DNA test will allow doctors to tailor treatment for patients based on their genetic make-up. 
"What you end up doing is treat the patients who will benefit from the current first line treatment, then you are able to prevent the other patients the drug won't do any good,  so you don't administer that drug, they don't suffer the side effects.  Instead you put them on a path for an alternative treatment," said Dr. Nowak. 
The company is also launching a clinical lab.

1 comment:

france pope said...

protein biomarker

Pretty good post. I just stumbled upon your blog and wanted to say that I have really

enjoyed reading your blog posts.

protein biomarker